• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    Pfizer, BioNTech Adapt COVID Vax Against Omicron

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement

    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement

    Qosina Strengthens Aseptic Capabilities

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies

    Antheia Receives $40 million in Venture Debt Financing
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    CMC Pharmaceuticals

    Quotient Sciences

    Societal CDMO

    Vector Partners Limited
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    CMC Pharmaceuticals

    Quotient Sciences

    Societal CDMO

    Vector Partners Limited
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Assessing Current DSCSA Implementation

    A detailed view of the industry’s progress with DSCSA Serialization Requirements.

    Assessing Current DSCSA Implementation
    Photo courtesy of GS1 US
    Related CONTENT
    • Mogene
    • Biopharma Over 20 Years
    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    • Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements
    • Exploring Potential Benefits of Outcomes-Based Contracts
    Peter Sturtevant, Senior Director Industry Development - Pharmaceuticals, GS1 US11.22.19
    A barcode assessment study conducted in the summer of 2019 indicates that the pharmaceutical industry is making steady progress toward serializing its products in accordance with the US FDA’s 2013 Drug Supply Chain Security Act (DSCSA) requirements, leading to improvedpatient safetyby enabling accurate identification and tracking of pharmaceutical products throughout the healthcare supply chain. Between 2018 and 2019, the percentage of products that were properly serialized increased dramatically from 20% to over 70%, marking a tremendous surge in momentum. 

    To obtain a view of industry’s progress, GS1 US collaborated with AmerisourceBergen Corporation and McKesson Pharmaceutical to assess the barcodes on packages of “lowest saleable units” in their distribution facilities. Cardinal Health and GS1 US also conducted barcode assessment for homogeneous cases from pharmaceutical manufacturers for the second year. The results are good news for the industry – and for patients.

    DSCSA Requirements
    The DSCSA requires pharmaceutical products to be serialized and labeled to support an interoperable, electronic system for identifying and tracing throughout their distribution in the United States. Four standardized data elements are required to be encoded in a barcode, including a National Drug Code (embedded in the  Global Trade Item Number®, GTIN®), serial number, lot number and expiration date. Packages (“lowest saleable units”) must be marked with a two-dimensional (2D) barcode (e.g., GS1 DataMatrix barcode), and homogeneous cases must include a 2D barcode or a linear barcode (e.g., GS1-128 barcode). The application of standardized data facilitates product traceability throughout the healthcare supply chain and will be used to associate the physical product markings with the serialized electronic data exchange required by November 27, 2023.

    Assessing Industry Readiness
    Three consecutive barcode assessments were conducted in 2017, 2018 and 2019 to obtain a yearly snapshot of the industry’s progress in meeting the requirements. The assessment was conducted by scanning over 50,000 barcodes on thousands of products within each of the Big 3 wholesalers’ distribution facilities to see if they scanned properly and contained all four required data elements. Each assessment showed a year-over-year improvement – from 2017 to 2018 the percentage of properly barcoded and serialized packages went from 7 to 20 percent. The dramatic change, however, occurred between the 2018 and 2019 assessments: all the way to 74 percent of products in inventory successfully meeting the standard.

    In the latest assessment, nearly 18,000 barcodes produced by 747 manufacturers were scanned at AmerisourceBergen and McKesson distribution centers, and another 19,000 linear and 2D barcodes on approximately 8,000 cases from 177 manufacturers were scanned at Cardinal Health facilities. Results showed that 74.3% of pharmaceutical barcodes scanned in the wholesalers’ facilities met the requirements—a 54% year-over-year improvement when compared to the same study conducted in 2018.

    Grandfathered products dwindling
    The FDA allowed products that were placed into commerce before November 27, 2018 to be “grandfathered,” exempting them from serialization enforcement under DSCSA. This allowed the industry to prevent shortages and ensure that patients could obtain proper medications when needed. The average expiration date of products found in inventory during the 2018 assessment was 2.3 years; in 2019, it went down to 1.6 years. As those products are used up or expire, the percentage of fully serialized products in the supply chain will continue to go up, heading towards the goal of 100 percent.   

    Learning curve
    The first two assessments revealed problems with the application of barcode standards, such as expiration date discrepancies and barcode legibility issues. By 2019 these anomalies had been almost entirely resolved. As a result, nearly all barcodes scanned properly, which saves time and improves accuracy by eliminating the need to resort to manual data entry.

    The wholesalers found that talking with their suppliers was crucial to work through any quality issues. By testing the barcode consistency in three consecutive years and collaborating with each other, they were able to adjust and improve. Periodic check-ups enable them to follow up and share results with their individual supplier manufacturers and repackagers so that they can continue to make any course corrections, as needed.

    Using the encoded information to benefit patients
    One of the benefits of standardized data capture is interoperability for information exchange between trading partners. The industry began using the barcode data for saleable returns verification in November 2019, enabling confirmation of returned pharmaceutical products’ eligibility for resale. That is just the beginning.

    The full impact of serialization will begin to be realized in 2023, when DSCSA requires implementation of an electronic, interoperable system for product traceability. At that point, transaction information for each sale of certain prescription drugs will be exchanged electronically to verify product identifiers at the package level. Such unprecedented levels of specific information sharing will enable cost savings, transactional accuracy improvements and more efficient recalls when needed, ultimately making the drug supply safer for patients.
     
    For more information about serializing pharmaceutical products, download the GS1 US Implementation Guideline: Applying GS1 Standards for DSCSA and Traceability. To access the 2019 GS1 US Barcode Assessment report, please visit www.gs1us.org/barcode-readability.
    Related Searches
    • patients
    • serialization
    • Testing
    • supply chain
    Suggested For You
    Mogene Mogene
    Biopharma Over 20 Years Biopharma Over 20 Years
    Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements
    Exploring Potential Benefits of Outcomes-Based Contracts Exploring Potential Benefits of Outcomes-Based Contracts
    Pharma Manufacturing: Methods for Real-Time Microbiology Pharma Manufacturing: Methods for Real-Time Microbiology
    Quality Metrics Feedback Quality Metrics Feedback
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Growth in Biologics and Maintaining Patient Satisfaction  Growth in Biologics and Maintaining Patient Satisfaction
    NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing
    FDA Accepts RedHill Biopharma’s NDA for Talicia FDA Accepts RedHill Biopharma’s NDA for Talicia
    The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up? The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
    Sierra’s Momelotinib Granted FDA Fast Track Designation Sierra’s Momelotinib Granted FDA Fast Track Designation
    Risk-Based Monitoring Risk-Based Monitoring
    The Orphan Promise The Orphan Promise

    Related Content

    • Mogene

      ...
      Craig Morley, CEO 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future

      ...
      10.28.19


    • Breaking News | Packaging & Tracking | Serialization | Supply Chain
      Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements

      Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements

      GS1 US Barcode Assessment Shows 74% of scanned barcodes meet serialization requirements.
      10.24.19

    • Exploring Potential Benefits of Outcomes-Based Contracts

      Exploring Potential Benefits of Outcomes-Based Contracts

      Achieving a successful transition, the benefits, potential downside, and looking forward
      Dean Erhardt, President and CEO, D2 Consulting 09.25.19

      Loading, Please Wait..
      Trending
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • 17th Annual Contracting & Outsourcing Conference Photos
      • Regulatory Report: Analytical Procedure Development
      • Machine Learning-based Predictive Modeling: Notable Uses In Clinical Trials
      • MilliporeSigma Opens $65M CDMO Facility For Cancer Therapies
      Breaking News
      • Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
      • Pfizer, BioNTech Adapt COVID Vax Against Omicron
      • CoreRx Expands Capabilities
      • Qosina Strengthens Aseptic Capabilities
      • Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Japanese Mushroom Extract Appears Helpful in HPV Infections
      Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
      United Plant Savers Launches First Film Festival
      Coatings World

      Latest Breaking News From Coatings World

      H.M. Royal Becomes Exclusive OCSiAl Distributor
      American Colors to Expand Sandusky, Ohio Facility
      Vaughn O’Dea Named Director of Epoxytec
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Accelmed Partners II, Lauxera Capital Partners Invest in Veranex
      Agnes Lee Named SVP of Investor Relations, Strategic Planning at Inogen
      Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
      Pfizer, BioNTech Adapt COVID Vax Against Omicron
      CoreRx Expands Capabilities
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Top 5 Beauty Tech Trends at Perfect Corp.'s Global Forum
      John Frieda Supports the LGBTQIA+ Community
      Athena Club Launches in Canada
      Happi

      Latest Breaking News From Happi

      Past Henkel Exec Christian Chopra Named President of Scotch Porter
      Color Street Celebrates Foster, Adoption Awareness with Limited-Edition Print
      CIR Panel Conducts 161st Meeting Regarding Safety Assessments for Cosmetic Ingredients
      Ink World

      Latest Breaking News From Ink World

      Dr. Tammo Boinowitz to Join Management Board of ALTANA AG
      Flint Offset Packaging Solutions Announces Price Increases for Sheetfed Inks
      Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Harveer Sahni recognized with Global Achievement Award
      Color-Logic partners with Taktiful 
      ALTANA announces Management Board change
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Fibertex Personal Care Awarded EcoVadis Awards for Sustainability
      Yanpai Orders Batt Forming Equipment for Needlepunch Line
      Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Researchers Discover Novel Patching Material for Bone Defects
      Boston Centerless Opens Second Manufacturing Plant in Indiana
      Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Identiv-Powered CVS Spoken Rx Wins NFC Forum 2022 Innovation Award
      LG Display Announces Winners of This Year’s OLEDs GO! Competition
      Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login